Finch Therapeutics Group, Inc.
FNCH
$13.45
-$0.55-3.93%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
10/21/2024
-
Globe Newswire
5/13/2024
-
InvestorPlace
5/1/2024
-
Ticker Report
4/21/2024
-
Zolmax
4/16/2024
-
Zolmax
4/8/2024
-
Benzinga
4/5/2024
-
Ticker Report
4/1/2024
-
Zolmax
3/26/2024
-
InvestorPlace
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, August 13, 2024
Period Date
Sunday, June 30, 2024
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 229 6499
Address
75 State Street
Boston, MA 02109
Boston, MA 02109
Country
Year Founded
Business Description
Sector
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops...
more
